| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.18 | 0.0006 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.092 | 0.003 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |